Research and Markets: Lymphoblastic Lymphoma Market Analysis 2015 - Global API Manufacturers and Phase III Pipeline Assessment

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/zf3xhf/lymphoblastic) has announced the addition of the "Lymphoblastic Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment" report to their offering.

Lymphoblastic Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication.

A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.

The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Key Topics Covered:

  1. Indication Overview
  2. Marketed Drugs Assessment
  3. Marketed Details of Drugs by Application Type
  4. Marketed Details of Drugs (NDA) by Marketing Status
  5. Marketed Details of Drugs by Patent Expiration Timeline
  6. The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
  7. The API Manufacturers by the United States Drug Master File (US DMF) Status
  8. The API Manufacturers by the US DMF Status (Drug Specific)
  9. The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
  10. The API Manufacturers by the US DMF Status (Drug Specific)
  11. Drugs Market Data and Forecasted Sales Figures (2011-2015)
  12. Marketed Drugs Information
  13. Drugs Description
  14. Route of Synthesis
  15. Global Active Pharmaceutical Manufacturers
  16. Approval Status
  17. Patent and Exclusivity Details
  18. Company Overview
  19. Phase III Drugs Information
  20. Phase III Drugs Description
  21. The United States Drug Master Filings (US DMF)
  22. Discontinued Drugs Information

Companies Mentioned

  • GlaxoSmithKline plc
  • Baxter Healthcare Corporation
  • Pfizer Inc.

For more information visit http://www.researchandmarkets.com/research/zf3xhf/lymphoblastic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals